Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q5BH69

Entry ID Method Resolution Chain Position Source
AF-Q5BH69-F1 Predicted AlphaFoldDB

No variants for Q5BH69

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q5BH69

No associated diseases with Q5BH69

12 regional properties for Q5BH69

Type Name Position InterPro Accession
repeat HAT (Half-A-TPR) repeat 63 - 95 IPR003107-1
repeat HAT (Half-A-TPR) repeat 107 - 139 IPR003107-2
repeat HAT (Half-A-TPR) repeat 141 - 175 IPR003107-3
repeat HAT (Half-A-TPR) repeat 291 - 326 IPR003107-4
repeat HAT (Half-A-TPR) repeat 394 - 432 IPR003107-5
repeat HAT (Half-A-TPR) repeat 434 - 470 IPR003107-6
repeat HAT (Half-A-TPR) repeat 524 - 556 IPR003107-7
repeat HAT (Half-A-TPR) repeat 558 - 592 IPR003107-8
repeat HAT (Half-A-TPR) repeat 595 - 629 IPR003107-9
repeat HAT (Half-A-TPR) repeat 667 - 701 IPR003107-10
repeat HAT (Half-A-TPR) repeat 703 - 737 IPR003107-11
repeat Tetratricopeptide repeat 421 - 449 IPR019734

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

3 GO annotations of cellular component

Name Definition
post-mRNA release spliceosomal complex A spliceosomal complex that is formed following the release of the spliced product from the post-spliceosomal complex and contains the excised intron and three snRNPs, including U5.
Prp19 complex A protein complex consisting of Prp19 and associated proteins that is involved in the transition from the precatalytic spliceosome to the activated form that catalyzes step 1 of splicing, and which remains associated with the spliceosome through the second catalytic step. It is widely conserved, found in both yeast and mammals, though the exact composition varies. In S. cerevisiae, it contains Prp19p, Ntc20p, Snt309p, Isy1p, Syf2p, Cwc2p, Prp46p, Clf1p, Cef1p, and Syf1p.
U2-type catalytic step 2 spliceosome A spliceosomal complex that contains the U2, U5 and U6 snRNPs bound to a splicing intermediate in which the first catalytic cleavage of the 5' splice site has occurred. The precise subunit composition differs significantly from that of the catalytic step 1, or activated, spliceosome, and includes many proteins in addition to those found in the U2, U5 and U6 snRNPs.

No GO annotations of molecular function

Name Definition
No GO annotations for molecular function

2 GO annotations of biological process

Name Definition
generation of catalytic spliceosome for first transesterification step Formation of a catalytic spliceosome complex ready to perform the first splicing reaction. This occurs by an ATP-dependent conformational change of the pre-catalytic spliceosome.
mRNA splicing, via spliceosome The joining together of exons from one or more primary transcripts of messenger RNA (mRNA) and the excision of intron sequences, via a spliceosomal mechanism, so that mRNA consisting only of the joined exons is produced.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MDRSSASRPD LYLIADNDSV YEQDLLRNPG TIKPWLAYIE YKQQNGTLYE QAFVGRPLDA
70 80 90 100 110 120
LIISILNDFQ VMERACKQLP RSYKLWKMYL EFRTKHLKNR NAIKYRAEFQ KVNTLFERAL
130 140 150 160 170 180
ILLNKMPRIW EMYLTFMLQQ PLVTQTRRTF DRALRALPVT QHNRIWKLYK TFARSASGQT
190 200 210 220 230 240
AVKIWARYMQ IHPENAEEYI NLLVEMGHYT DAIKRYMEIL DNPRFQSREG KSNFQLWTEM
250 260 270 280 290 300
VDLLVSKAKK IETGPQTGID VDAILRSGID RFADQRGKLW AGLATYWITK GNFEKARDVF
310 320 330 340 350 360
EEGITTVMTV RDFTLIFDSY VEFEESIIGS LMEAAAVRAD NGKADEEADF DLDLRMLRFE
370 380 390 400 410 420
QLMDRRPFLV NDVLLRQNPN NVIEWEKRVA LWGDNNVEIV NTYTAAIAAI NPKKAVGKFS
430 440 450 460 470 480
ELWVNYAKFY ERGGDLDTAR IIFEKAVKVP FKSVNELAET WCEWAEMELR SENFDKAVEI
490 500 510 520 530 540
MAKATQAPKK STVDYFDETL SPQQRIHKSW KLWSFYVDLV ESVSSIEETK KVYERIFELR
550 560 570 580 590 600
IATPQTVVNY ANLLEEHKYF EESFKVYERG LDLFTYPVAF ELWNLYLTKA VDRKIGIERL
610 620 630 640 650 660
RDLFEQALDG CPPKFARPLY LMYGNLEEER GLARHAMRIY ERATRAVSDE DRFEMFEFYI
670 680 690 700 710 720
TKSASNFGLP STRPIYERAI AALPDHEAKE MCLKFAEMER RLGEIDRARA IYGHASQFCD
730 740 750 760 770 780
PRTNAPFWQK WEAFEVQHGN EDTFKEMLRI KRSVQAQYNT DVNFIASQAI ARSQQRAPEG
790 800 810 820 830 840
EEATAAAERE MDTETTDAMA ALERQARAPI GFVAASTGPE GGNRAPPAGQ GPVAAPANPD
850
AIDLDDDMEA D